Clinical Trial Patient Technology

CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS

Digital Endpoints Are Ready. Clinical Development Isn't
Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
Cleaning data is no longer an afterthought; it’s a continuous, risk-based must-have that protects integrity, ensures compliance, and drives reliable results.

Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT

Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
Control And Transparency: Solving Sponsors' Key Challenges In Study Launch

Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.
Patient First Solutions For Oncology

Medable, Inc's new oncology offering is an end-to-end suite that includes an extensive eCOA library, pre-built and validated DCT applications such as Total Consent and Televisit, and protocol design consulting.

The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials

Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
Designing ePRO and eConsent Solutions that Participants and Sites Want

Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value.
Gradually Investing In Direct Data Capture Is Inevitable

Given study decentralization and the many electronic sources of data now available, it is time for sponsors and contract research organizations to face the inevitable: EDCs need to be “sunsetted.”

Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials

Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.
Simple, Cost-Effective Ways To Engage Patients Using eCOA And IRT

Today, patients are exposed to sophisticated technology, which presents a huge opportunity to elevate engagement. Consider some common elements when initiating engagement during clinical development.
Designing ePRO and eConsent Solutions that Participants and Sites Want

Participant-focused eClinical technologies offer significant potential to decrease paper-based processes and improve end-user experiences in collecting patient-reported outcomes (PRO) and informed consent, but many users continue to experience rigid technology, complicated hardware provisioning processes, and clunky implementations that leave sponsors, CROs and sites questioning the value.